| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| Company: Puma Biotechnology |
| Recipient: You |
| Company: Mylan |
| Recipient: You |
| Company: Samsung Bioepis |
| Recipient: You |
| Company: Chugai Pharma |
| Recipient: You |
| Company: Blueprint Medicines |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: Napo Pharmaceuticals |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: OBI Pharma |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Odonate Therapeutics |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: Sermonix Pharmaceuticals |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Ayala Pharmaceuticals |
| Recipient: Your Institution |
| Company: Astellas Pharma |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
| Company: Macrogenics |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
| Company: Polyphor |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
|
| Open Payments URL: https://openpaymentsdata.cms.gov/summary |
|